3 products in acute respiratory diagnosis, chronic respiratory management and OSA which all have massive revenue potential, this will be doubtful. IMO, the global revenue for just SleepCheck can bring in $4M.
3 products in acute respiratory diagnosis, chronic respiratory...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #